Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license research and collaborat... Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single in-office intravitreal IVT injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust sustained treatment response reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor VEGF injections. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.02 | -20 | 5.1 | 5.445 | 4.08 | 130559 | 4.96739779 | CS |
| 4 | -0.77 | -15.8762886598 | 4.85 | 5.7237 | 3.92 | 140324 | 4.78257981 | CS |
| 12 | -1 | -19.6850393701 | 5.08 | 5.7237 | 3.52 | 170601 | 4.46509125 | CS |
| 26 | -2.82 | -40.8695652174 | 6.9 | 8.56 | 3.52 | 202126 | 5.73171013 | CS |
| 52 | -10.06 | -71.1456859972 | 14.14 | 14.21 | 3.52 | 254303 | 7.31596515 | CS |
| 156 | -9.22 | -69.3233082707 | 13.3 | 29.8 | 3.52 | 618757 | 12.77379638 | CS |
| 260 | -105.42 | -96.2739726027 | 109.5 | 269.8 | 3.52 | 1000784 | 48.90346933 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
